Production (Stage)
Microbix Biosystems Inc.
MBX.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -94.86% | -66.08% | -78.32% | 131.49% | 1,097.44% |
| Total Depreciation and Amortization | -0.50% | 1.67% | 111.05% | 37.66% | 34.08% |
| Total Amortization of Deferred Charges | -- | -- | -75.43% | -- | -- |
| Total Other Non-Cash Items | -13.95% | -5.41% | 109.00% | -58.44% | 14.14% |
| Change in Net Operating Assets | 193.10% | 57.13% | 66.04% | -74.20% | 85.20% |
| Cash from Operations | 8.21% | -42.46% | 151.73% | -35.35% | 179.75% |
| Capital Expenditure | 63.88% | -437.41% | -91.47% | -234.17% | -16.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 63.88% | -437.41% | -91.47% | -357.65% | -16.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,568.76% | 0.14% | 0.00% | -312.13% | 1.48% |
| Issuance of Common Stock | 665.97% | -- | -- | -- | 310.69% |
| Repurchase of Common Stock | -88.38% | -872.05% | -67.20% | 2.11% | 1.25% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 750.49% | -289.95% | -64.32% | -99.71% | -112.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,452.62% | -93.00% | 108.43% | -103.74% | 112.86% |